FDA Warning Letter to Warrior Labz SARMS
FDA cited Warrior Labz for marketing BPC-157 and TB-500 products as unapproved new drugs.
Not legal or medical advice.
This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.
U.S. Food and Drug AdministrationWarning letterPublished
- Docket / Citation
- 655280
- Published
- 2023-06-12